Temsirolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

NCT00316849 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

56

Enrollment

NIH

Sponsor class

Conditions

Adult Giant Cell Glioblastoma
Adult Glioblastoma
Adult Gliosarcoma

Interventions

OTHER: pharmacological study
PROCEDURE: adjuvant therapy
RADIATION: 3-dimensional conformal radiation therapy
RADIATION: intensity-modulated radiation therapy
DRUG: temsirolimus
DRUG: temozolomide

Sponsor

National Cancer Institute (NCI)